An observational study in Peri-implantitis and Peri-implant Bone Loss, sponsored by Arrow Development. Recruiting at 9 sites in Spain. Per ClinicalTrials.gov, last updated 2026-10-13.
Sponsored by Arrow Development · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 50 studies in Peri-Implantitis with a site in Spain — 16 open to participants now, 19 under way, none of them phase 3. Peri-Implantitis · Spain.
Among the 50 studies in Peri-Implantitis with a site in Spain, this one has the largest planned enrollment of the 22 observational ones that give a count, is one of 6 that started in 2026, is one of 22 observational ones, reaches primary completion later than 13 of the 18 other live ones, and was the 44th registered.
324 studies on the registry are indexed under Peri-Implantitis; 89 are open to participants now.
Browse Peri-Implantitis studies →16 of the 50 studies in Peri-Implantitis with a site in Spain are open now. Recruiting first, the newest first:
Center of Implantology, Oral and Maxillofacial Surgery, Badajoz, Spain · Sites in Spain
Ages up to 90 · Healthy volunteers
Bioteck S.p.A. · Sites in Spain
Ages 25–65
Universitat Internacional de Catalunya · Sites in Spain
Ages 18+ · Healthy volunteers
Universitat Internacional de Catalunya · Sites in Spain
Ages 18+ · Healthy volunteers
Universidad de Murcia · Sites in Spain
Healthy volunteers
A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →
Of the 50 Peri-Implantitis studies recruiting now, 28 (56%) set no upper age limit and 9 (18%) stop at 75 or younger; 7 take children under 18; 26 take healthy volunteers.
This study: all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
50 studies; the count open now beside each. This study's row is marked.
First in 2013; this study’s year is marked. 6 started in 2026.
This study's planned enrollment of 281 is above the median of 84 across 122 observational studies indexed under Peri-Implantitis.
Median enrollment 37 across the 27 interventional studies, 117 across the 22 observational. Of the 26 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
3 of 50 have an industry lead sponsor. The 10 most frequent:
This is the only study on the registry with Arrow Development as lead sponsor.
Arrow Development has 1 study filed under Peri-Implantitis — fewer than ten, so there is no comparison to draw.
5 of the studies in Peri-Implantitis with a site in Spain that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07557459Arrow DevelopmentAccess to Probing and Peri-implant Diseases | 2027-05 |
| NCT07638969Center of Implantology, Oral and Maxillofacial Surgery, Badajoz, SpainOccurrence of Peri-Implant Complications: A Multifactorial Cross-Sectional Study | 2027-07-01 |
| NCT07590037University of BarcelonaComparison of Anesthetic Efficacy and Safety Between Inferior Alveolar Nerve Block and the Infiltrative Technique for the Treatment of Peri-implant Diseases in Posterior Mandibular Implants | 2027-09 |
| NCT07694323University of BarcelonaPatient Perspectives Throughout Peri-Implantitis Treatment | 2027-09-03 |
| NCT07680491Bioteck S.p.A.Non-surgical Treatment of Peri-implant Pockets With H42 | 2027-09-30 |
Add all 5 to your calendar (.ics) → With an account.
Among the 50 studies in Peri-Implantitis with a site in Spain, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This multicenter cross-sectional study aims to evaluate the association between access to peri-implant probing and radiographic peri-implant bone loss. Although probing is the primary diagnostic tool for peri-implant diseases, prosthetic design may limit access, potentially affecting diagnosis and disease progression. The study will include patients with dental implants in function for at least three years and will assess clinical, radiographic, and prosthetic variables.
Peri-implantitis is a plaque-induced inflammatory condition characterized by inflammation of peri-implant tissues and progressive bone loss. Probing is essential for diagnosis; however, prosthetic design may hinder or prevent proper probing access, potentially compromising diagnostic accuracy.
Despite its clinical relevance, no studies have directly evaluated whether limited access to probing is associated with peri-implant bone loss. This study aims to address this gap.
This is a multicenter cross-sectional observational study conducted in nine private clinics in Spain. A total of 281 patients will be included. Clinical and radiographic data will be collected, including probing accessibility, probing depth, plaque index, bleeding on probing, suppuration, prosthetic design, hygiene accessibility, and radiographic bone levels.
Statistical analysis will evaluate associations between probing access and peri-implant bone loss at both patient and implant levels.
Adult patients attending participating clinics for the first time for maintenance, review, or treatment, with dental implants in function for at least three years
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
This is a non-interventional, observational cross-sectional multicenter study. No therapeutic, surgical, or pharmacological interventions are performed as part of the study. All procedures correspond to standard clinical practice and include: Peri-implant clinical examination, consisting of probing depth measurements at six sites per implant using a manual periodontal probe. When access is limited, a flexible plastic probe may be used. Assessment of probing accessibility, categorized according to the angulation and feasibility of probe insertion without prosthesis removal (possible, limited, or impossible). Recording of routine clinical parameters, including plaque presence, bleeding on probing, suppuration, and patient-reported hygiene practices. Radiographic assessment, consisting of standardized periapical radiographs obtained using a parallel technique for the evaluation of marginal bone levels. No modifications to the patients' treatment, prosthetic design, or maintenance protocol
Association between probing access and peri-implant radiographic bone loss
Evaluation of whether limited or impossible probing access is associated with increased radiographic bone loss (measured in mm from implant platform to bone level).
Time frame: Baseline (cross-sectional assessment)
Prevalence of implants with limited or no probing accessibility
Proportion of implants classified as having limited or impossible access to peri-implant probing, based on probe angulation and feasibility without prosthesis removal.
Time frame: Assessed at the baseline visit (single cross-sectional evaluation)
Prevalence of non-hygienizable implant-supported prostheses
Proportion of implant-supported restorations classified as non-hygienizable, defined as the inability to pass an interdental brush of at least 0.4 mm diameter
Time frame: Assessed at the baseline visit (single cross-sectional evaluation)
Association between hygiene accessibility and peri-implant bone loss
Evaluation of the relationship between prosthetic hygiene accessibility (hygienizable vs non-hygienizable) and radiographic peri-implant marginal bone levels.
Time frame: Assessed at the baseline visit (single cross-sectional evaluation)
Clinical peri-implant parameters
Assessment of peri-implant clinical parameters, including plaque presence, bleeding on probing, suppuration, and probing depth (when measurable), in relation to probing accessibility.
Time frame: Assessed at the baseline visit (single cross-sectional evaluation)
Patient-related and implant-related factors associated with probing accessibility
Exploratory analysis of the association between probing accessibility and variables such as type of prosthesis (single, partial, full-arch), implant characteristics (bone level/tissue level, connection type), and patient-related factors (oral hygiene habits, maintenance frequency, history of periodontitis).
Time frame: Assessed at the baseline visit (single cross-sectional evaluation)
Plan to share: No
No publications or documents are linked to this record.
Started Sep 2026 (actual). Primary completion is estimated for May 2027, 8 months after the start.
Start moved once since we started tracking on Sep 25, 2026: May 2026 → Sep 2026, on Oct 13, 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.